Eduard Sanders
Variation in antiviral immunity and inflammation pathways precedes HIV-1 infection in a high-risk African cohort.Kioko, M.
Mwangi, S.
Fwambah, L.
Hassan, A. S.
Blackard, J. T.
Bejon, P.
Sanders, E.
Ndung'u, T.
Nduati, E. W.
Abdi, A. I.
J Clin Invest, (2026). 136:
Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.Nazziwa, J.
Freyhult, E.
Hong, M. G.
Johansson, E.
Arman, F.
Hare, J.
Gounder, K.
Rezeli, M.
Mohanty, T.
Kjellstrom, S.
Kamali, A.
Karita, E.
Kilembe, W.
Price, M. A.
Kaleebu, P.
Allen, S.
Hunter, E.
Ndung'u, T.
Gilmour, J.
Rowland-Jones, S. L.
Sanders, E.
Hassan, A. S.
Esbjornsson, J.
Nat Commun, (2024). 15:10593
There are three major Neisseria gonorrhoeae beta-lactamase plasmid variants which are associated with specific lineages and carry distinct TEM alleles.Elsener, T. A.
Jolley, K. A.
Sanders, E.
Maiden, M. C. J.
Cehovin, A.
Tang, C. M.
Microb Genom, (2023). 9:
Integrating HIV and mental health interventions to address a global syndemic among men who have sex with men.Operario, D.
Sun, S.
Bermudez, A. N.
Masa, R.
Shangani, S.
van der Elst, E.
Sanders, E.
Lancet HIV, (2022). 9:e574-e584
Complete Genome Sequences of Dengue Virus Type 2 Strains from Kilifi, Kenya.Kamau, E.
Agoti, C. N.
Ngoi, J. M.
de Laurent, Z. R.
Gitonga, J.
Cotten, M.
Phan, M. V. T.
Nokes, D. J.
Delwart, E.
Sanders, E.
Warimwe, G. M.
Microbiol Resour Announc, (2019). 8:
Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.van Santen, D. K.
van der Helm, J. J.
Touloumi, G.
Pantazis, N.
Muga, R.
Gunsenheimer-Bartmeyer, B.
Gill, M. J.
Sanders, E.
Kelleher, A.
Zangerle, R.
Porter, K.
Prins, M.
Geskus, R. B.
Cascade Collaboration within EuroCoord
AIDS, (2019). 33:327-337
Public/community engagement in health research with men who have sex with men in sub-Saharan Africa: challenges and opportunities.Molyneux, S.
Sariola, S.
Allman, D.
Dijkstra, M.
Gichuru, E.
Graham, S.
Kamuya, D.
Gakii, G.
Kayemba, B.
Kombo, B.
Maleche, A.
Mbwambo, J.
Marsh, V.
Micheni, M.
Mumba, N.
Parker, M.
Shio, J.
Yah, C.
van der Elst, E.
Sanders, E.
Health Res Policy Syst, (2016). 14:40
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.Wallis, C. L.
Papathanasopoulos, M. A.
Lakhi, S.
Karita, E.
Kamali, A.
Kaleebu, P.
Sanders, E.
Anzala, O.
Bekker, L. G.
Stevens, G.
de Wit, T. F.
Stevens, W.
J Virol Methods, (2010). 163:505-8
